Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-25 @ 1:34 AM
NCT ID:
NCT01895894
Eligibility Criteria:
Inclusion Criteria:
* Steroid-dependent patients who had been on calcineurin inhibitors continuously for more than 1 year
* in complete remission
Exclusion Criteria:
* Hereditary or secondary nephrotic syndrome
* Estimated glomerular filtration rate (GFR) \< 60 mg/min/1.73 m\^2
* Body weight \<16 kg
* leukocytopenia (absolute neutrophil count \< 2000/mm\^3) or anemia(Hct \< 25%)
* Severe gastrointestinal disease
* chronic or acute active infection (e.g. hepatitis B,C, herpes, varicella zoster)
* prior live vaccine inoculation within 6 weeks (from the study enrollment)
* GOT/GPT elevation or hyperbilirubinemia
* malignant disease
* Pregnant or Breast feeding
* Previous history of mycophenolate mofetil use
* Participation to other therapeutic trial within recent 3 months
* Deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
24 Years
Study:
NCT01895894
Study Brief:
Protocol Section:
NCT01895894